Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

Cell

Volumn 114, Issue 1, 2003, Pages 21-31

  Mariani, Roberto ^a   Chen, Darlene ^a   Schröfelbauer, Bärbel ^a   Navarro, Francisco ^a   König, Renate ^a   Bollman, Brooke ^a   Münk, Carsten ^a   Nymark McMahon, Henrietta ^a   Landau, Nathaniel R ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; VIF PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; RNA EDITING; VIRION; VIRUS REPLICATION; WILD TYPE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0038107587     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00515-4     Document Type: Article

References (52)

1. Anant S., MacGinnitie A.J., Davidson N.O. apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J. Biol. Chem. 270:1995;14762-14767.
2. Borman A.M., Quillent C., Charneau P., Kean K.M., Clavel F. A highly defective HIV-1 group O provirus. evidence for the role of local sequence determinants in G→A hypermutation during negative-strand viral DNA synthesis Virology. 208:1995;601-609.
3. Butler S.L., Hansen M.S., Bushman F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 7:2001;631-634.
4. Camaur D., Trono D. Characterization of human immunodeficiency virus type 1 Vif particle incorporation. J. Virol. 70:1996;6106-6111.
5. Chowdhury I.H., Chao W., Potash M.J., Sova P., Gendelman H.E., Volsky D.J. vif-negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus. J. Virol. 70:1996;5336-5345.
6. Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 206:1995;936-944.
7. Deng D., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., DiMarzio P., Marmon S., Sutton R.E., Hill C.M.et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
8. Desrosiers R.C., Lifson J.D., Gibbs J.S., Czajak S.C., Howe A.Y., Arthur L.O., Johnson R.P. Identification of highly attenuated mutants of simian immunodeficiency virus. J. Virol. 72:1998;1431-1437.
9. Dettenhofer M., Yu X.F. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. J. Virol. 73:1999;1460-1467.
10. Emerman M., Malim M.H. HIV-1 regulatory/accessory genes. keys to unraveling viral and host cell biology Science. 280:1998;1880-1884.
11. Foley G.E., Handler A.H., Lynch P.M., Wolman S.R., Stulberg C.S., Eagle H. Loss of neoplastic properties in vitro. II. Observations on KB sublines. Cancer Res. 25:1965;1254-1261.
12. Fouchier R.A., Simon J.H., Jaffe A.B., Malim M.H. Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins. J. Virol. 70:1996;8263-8269.
13. Gabuzda D.H., Lawrence K., Langhoff E., Terwilliger E., Dorfman T., Haseltine W.A., Sodroski J. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes. J. Virol. 66:1992;6489-6495.
14. Gaddis N.C., Chertova E., Sheehy A.M., Henderson L.E., Malim M.H. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions. J. Virol. 77:2003;5810-5820.
15. Goncalves J., Korin Y., Zack J., Gabuzda D. Role of Vif in human immunodeficiency virus type 1 reverse transcription. J. Virol. 70:1996;8701-8709.
16. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell. 28:2003;803-809.
17. Harris R.S., Petersen-Mahrt S.K., Neuberger M.S. RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell. 10:2002;1247-1253.
18. Honjo T., Kinoshita K., Muramatsu M. Molecular mechanism of class switch recombination. linkage with somatic hypermutation Annu. Rev. Immunol. 20:2002;165-196.
19. Jarmuz A., Chester A., Bayliss J., Gisbourne J., Dunham I., Scott J., Navaratnam N. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics. 79:2002;285-296.
20. Jutila M.A., Bargatze R.F., Kurk S., Warnock R.A., Ehsani N., Watson S.R., Walcheck B. Cell surface P- and E-selectin support shear-dependent rolling of bovine gamma/delta T cells. J. Immunol. 153:1994;3917-3928.
21. Keppler O.T., Yonemoto W., Welte F.J., Patton K.S., Iacovides D., Atchison R.E., Ngo T., Hirschberg D.L., Speck R.F., Goldsmith M.A. Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J. Virol. 75:2001;8063-8073.
22. Keppler O.T., Welte F.J., Ngo T.A., Chin P.S., Patton K.S., Tsou C.L., Abbey N.W., Sharkey M.E., Grant R.M., You Y.et al. Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1. J. Exp. Med. 195:2002;719-736.
23. Khan M.A., Aberham C., Kao S., Akari H., Gorelick R., Bour S., Strebel K. Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. J. Virol. 75:2001;7252-7265.
24. Krokan H.E., Drablos F., Slupphaug G. Uracil in DNA-occurrence, consequences and repair. Oncogene. 21:2002;8935-8948.
25. Lau P.P., Villanueva H., Kobayashi K., Nakamuta M., Chang B.H., Chan L. A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. J. Biol. Chem. 276:2001;46445-46452.
26. Lecossier D., Bouchonnet F., Clavel F., Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science. 300:2003;1112.
27. Lenburg M.E., Landau N.R. Vpu-induced degradation of CD4. requirement for specific amino acid residues in the cytoplasmic domain of CD4 J. Virol. 67:1993;7238-7245.
28. Liu H., Wu X., Newman M., Shaw G.M., Hahn B.H., Kappes J.C. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J. Virol. 69:1995;7630-7638.
29. Madani N., Kabat D. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J. Virol. 72:1998;10251-10255.
30. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Nature, in press. Published online. May 28:2003;2003. 10.1038/nature01709.
31. Morgenstern J.P., Land H. Advanced mammalian gene transfer. high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line Nucleic Acids Res. 18:1990;3587-3596.
32. Muto T., Muramatsu M., Taniwaki M., Kinoshita K., Honjo T. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics. 68:2000;85-88.
33. Nara P.L., Fischinger P.J. Quantitative infectivity assay for HIV-1 and-2. Nature. 332:1988;469-470.
34. Oberste M.S., Gonda M.A. Conservation of amino-acid sequence motifs in lentivirus Vif proteins. Virus Genes. 6:1992;95-102.
35. Onishi M., Kinoshita S., Morikawa Y., Shibuya A., Phillips J., Lanier L.L., Gorman D.M., Nolan G.P., Miyajima A., Kitamura T. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24:1996;324-329.
36. Puck T.T. Genetics of somatic mammalian cells III. Long-term cultivation of eupoid cells from human and animal subjects. J. Exp. Med. 108:1958;945-956.
37. Ralph P., Nakoinz I. Inhibitory effects of lectins and lymphocyte mitogens on murine lymphomas and myelomas. J. Natl. Cancer Inst. 51:1973;883-890.
38. Sheehy A.M., Gaddis N.C., Choi J.D., Malim M.H. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 418:2002;646-650.
39. Simon J.H., Malim M.H. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol. 70:1996;5297-5305.
40. Simon J.H., Southerling T.E., Peterson J.C., Meyer B.E., Malim M.H. Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol. 69:1995;4166-4172.
41. Simon J.H., Gaddis N.C., Fouchier R.A., Malim M.H. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat. Med. 4:1998;1397-1400.
42. Soares M.A., Robertson D.L., Hui H., Allan J.S., Shaw G.M., Hahn B.H. A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys. Virology. 228:1997;394-399.
43. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman S.M., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:1995;628-633.
44. Strebel K., Daugherty D., Clouse K., Cohen D., Folks T., Martin M.A. The HIV 'A' (sor) gene product is essential for virus infectivity. Nature. 328:1987;728-730.
45. Trono D. HIV accessory proteins. leading roles for the supporting cast Cell. 82:1995;189-192.
46. Vartanian J.P., Meyerhans A., Asjo B., Wain-Hobson S. Selection, recombination, and G→A hypermutation of human immunodeficiency virus type 1 genomes. J. Virol. 65:1991;1779-1788.
47. Vartanian J.P., Meyerhans A., Sala M., Wain-Hobson S. G→A hypermutation of the human immunodeficiency virus type 1 genome. evidence for dCTP pool imbalance during reverse transcription Proc. Natl. Acad. Sci. USA. 91:1994;3092-3096.
48. Vartanian J.P., Henry M., Wain-Hobson S. Sustained G→A hypermutation during reverse transcription of an entire human immunodeficiency virus type 1 strain Vau group O genome. J. Gen. Virol. 83:2002;801-805.
49. von Schwedler U., Song J., Aiken C., Trono D. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:1993;4945-4955.
50. Wedekind J.E., Dance G.S., Sowden M.P., Smith H.C. Messenger RNA editing in mammals. new members of the APOBEC family seeking roles in the family business Trends Genet. 19:2003;207-216.
51. Yang Y., Sowden M.P., Smith H.C. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1. J. Biol. Chem. 275:2000;22663-22669.
52. Zhang H., Yang B., Pomerantz R.J., Zhang C., Shyamala C.A., Gao L. Nature, in press. Published online. May 28:2003;2003. 10.1038/nature01707.